Therefore, for people with a low infection risk, a universal booster vaccination is not currently recommended.
Therefore, for people with a low infection risk, a universal booster vaccination is not currently recommended, but it should be considered for high-risk groups.
Current consensus does not support the use of a universal booster of hepatitis B virus (HBV) vaccine because there is an anamnestic response in almost all children 15 years after universal infant HBV vaccination.
Since the highest incidence of the disease is currently reported among adolescents, a universal booster vaccination in this age class has been proposed.
The main goal of this paper is to design an individual-based stochastic dynamic framework to model the pertussis transmission in the population in order to predict the epidemiologic and economic consequences of the implementation of universal booster vaccination programs.
The aim of this study is to design an individual-based stochastic dynamic framework to model pertussis transmission in the population in order to predict the epidemiologic and economic consequences of the implementation of universal booster vaccination programs.
In conclusion, we designed a dynamic individual-based DES-model to model pertussis transmission in the population in order to estimate the cost-effectiveness of universal booster vaccination strategies.
Although universal booster dose may not be necessary up to 20 years after the primary vaccination because HBsAg and anti-HBc seropositivity did not increase [ 7], the methods for the prevention of horizontal transmission, such as avoidance of skin tattooing, use of disposable needles, and condom use in sexual contact still need continuous implementation in the adolescent group [ 25].
Furthermore, we applied this model to estimate the cost-effectiveness of a universal adolescent booster vaccination program for the Dutch situation.
A universal decennial Tdap booster program should be implemented starting in preadolescents and continuing throughout adulthood, including persons aged ≥65 years.
